novo nordisk lawsuit semaglutide is suing U.S. telehealth company Hims and Hers, alleging patent infringement over its planned release of a knockoff version of its Wegovy weight loss pill. Hims and Hers is pushing back, Novo Nordisk Settles Ozempic Patent

The cataclysmic shift in food consumption for GLP-1 users shows early signs of positive health outcomes: GLP-1s have proven effective in managing blood glucose control and weight and improving the symptoms of diet-related disease like Type 2 diabetes and heart disease

An infusion of high-quality nutrients that fuel metabolism, support endurance and help you stay energized and focused on your goals

Patients in trials reported less breathlessness, better ability to walk or exercise, improved quality of life scores, weight loss, and better functional capacity

. , , ,

Ive been wanting to do an episode on this for a while, but havent known quite how to approach it